Cancer Registry St, Gallen-Appenzell, Cancer League Ostschweiz, St Gallen, Switzerland.
BMC Cancer. 2013 Jun 14;13:287. doi: 10.1186/1471-2407-13-287.
Cancer survivors are a heterogeneous group with complex health problems. Data concerning its total number and growing dynamics for Switzerland are scarce and outdated.
Population and mortality data were retrieved from the Swiss Federal Statistical Office (FSO). Incidence and relative survival for invasive cancers were computed using data from the cancer registries Geneva (1970-2009), St. Gallen - Appenzell (1980-2010), Grisons & Glarus (1989-2010), and Valais (1989-2010). We estimated prevalence for 1990-2010 using the Prevalence, Incidence Approach MODel (PIAMOD) method. We calculated trends in prevalence estimates by Joinpoint analysis. Projections were extrapolated using the above models and based on time trends of the period 2007-2010.
The estimated number of cancer survivors increased from 139'717 in 1990 (2.08% of the population) to 289'797 persons in 2010 (3.70%). The growth rate shows an exponential shape and was 3.3% per year in the period 2008 to 2010. Almost half of the survivors have a history of breast, prostate or colorectal cancer. Among cancer survivors, 55% are women but the increases have been more marked in men (p < 0.01, 3.9% annual increase in men vs. 2.7% in women since 2008). By the end of 2020 372'000 cancer survivors are expected to live in Switzerland.
There is a rapidly growing population of cancer survivors in Switzerland whose needs and concerns are largely unknown.
癌症幸存者是一个具有复杂健康问题的异质群体。有关瑞士癌症幸存者总数及其增长动态的数据稀缺且已过时。
人口和死亡率数据从瑞士联邦统计局(FSO)获取。使用来自日内瓦癌症登记处(1970-2009 年)、圣加仑-阿彭策尔(1980-2010 年)、格劳宾登州和格拉鲁斯州(1989-2010 年)以及瓦莱州(1989-2010 年)的数据计算了侵袭性癌症的发病率和相对生存率。我们使用流行率、发病率方法模型(PIAMOD)方法估算了 1990-2010 年的流行率。我们通过 Joinpoint 分析计算了流行率估计值的趋势。使用上述模型进行外推和预测,基于 2007-2010 年的时间趋势。
估计的癌症幸存者人数从 1990 年的 139717 人(占总人口的 2.08%)增加到 2010 年的 289797 人(3.70%)。增长率呈指数形状,2008 年至 2010 年期间每年增长 3.3%。近一半的幸存者患有乳腺癌、前列腺癌或结直肠癌。在癌症幸存者中,55%为女性,但男性的增长更为显著(p<0.01,自 2008 年以来男性每年增长 3.9%,女性每年增长 2.7%)。预计到 2020 年底,瑞士将有 372000 名癌症幸存者。
瑞士的癌症幸存者人数正在迅速增长,其需求和关注点在很大程度上尚未被了解。